i respect that, but technology in a world that quickly adopts technology, should not take this long.
I have commented way before this offer was around that I don't believe GP's want to use this technology, and that is the major hurdle this company has to get over. Unfortunately, the commercial accumen of TK is not strong enough and RAP will struggle for a long time if it is him running the business.
I would be way more interested if the company was disclosing usage statistics around the app. Medgate extending means nothing unless they are using it regularly - the figures don't yet show that.
quarterly tomorrow will be very interesting, and I may end up eating these words.
RAP Price at posting:
11.5¢ Sentiment: None Disclosure: Not Held